BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7766311)

  • 1. Induced terminal differentiation and tumorigenic suppression in murine keratinocyte somatic-cell hybrids.
    Schneider BL; Kulesz-Martin M; Bowden GT
    Mol Carcinog; 1995 May; 13(1):6-14. PubMed ID: 7766311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogene activation and tumor suppressor gene inactivation during multistage mouse skin carcinogenesis.
    Bowden GT; Schneider B; Domann R; Kulesz-Martin M
    Cancer Res; 1994 Apr; 54(7 Suppl):1882s-1885s. PubMed ID: 8137304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of an in vitro model to study carcinogen-induced neoplastic progression of initiated mouse epidermal cells.
    Morgan D; Welty D; Glick A; Greenhalgh D; Hennings H; Yuspa SH
    Cancer Res; 1992 Jun; 52(11):3145-56. PubMed ID: 1375535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a human chromosome 11 gene which is differentially regulated in tumorigenic and nontumorigenic somatic cell hybrids of HeLa cells.
    Lichy JH; Modi WS; Seuanez HN; Howley PM
    Cell Growth Differ; 1992 Aug; 3(8):541-8. PubMed ID: 1390339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The early genes E6 and E7 of cancer associated human papilloma viruses as targets of tumor suppression?
    Bosch FX; Dürst M; Schwarz E; Boukamp P; Fusenig NE; zur Hausen H
    Behring Inst Mitt; 1991 Jul; (89):108-21. PubMed ID: 1656929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stable nontumorigenic phenotype of somatic cell hybrids between malignant Burkitt's lymphoma cells and autologous EBV-immortalized B cells despite induction of chromosomal breakage and loss.
    Jox A; Taquia E; Vockerodt M; Draube A; Pawlita M; Möller P; Bullerdiek J; Diehl V; Wolf J
    Cancer Res; 1998 Nov; 58(21):4930-9. PubMed ID: 9810002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between the expression of differentiation-specific keratins 1 and 10 and cell proliferation in epidermal tumors.
    Kartasova T; Roop DR; Yuspa SH
    Mol Carcinog; 1992; 6(1):18-25. PubMed ID: 1380247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficiency of either cyclooxygenase (COX)-1 or COX-2 alters epidermal differentiation and reduces mouse skin tumorigenesis.
    Tiano HF; Loftin CD; Akunda J; Lee CA; Spalding J; Sessoms A; Dunson DB; Rogan EG; Morham SG; Smart RC; Langenbach R
    Cancer Res; 2002 Jun; 62(12):3395-401. PubMed ID: 12067981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smad3 regulates senescence and malignant conversion in a mouse multistage skin carcinogenesis model.
    Vijayachandra K; Lee J; Glick AB
    Cancer Res; 2003 Jul; 63(13):3447-52. PubMed ID: 12839923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A model for initiated mouse skin: suppression of papilloma but not carcinoma formation by normal epidermal cells in grafts on athymic nude mice.
    Strickland JE; Ueda M; Hennings H; Yuspa SH
    Cancer Res; 1992 Mar; 52(6):1439-44. PubMed ID: 1540951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of multiple tumor suppressor genes for Syrian hamster fibrosarcomas by somatic cell hybridization.
    Whitehead RE; Sugawara O; Maronpot RR; Gladen BC; Barrett JC
    Somat Cell Mol Genet; 1992 Mar; 18(2):131-42. PubMed ID: 1574739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evidence for human tumor suppressor genes.
    Stanbridge EJ
    Princess Takamatsu Symp; 1989; 20():3-13. PubMed ID: 2577336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of plasminogen activator inhibitor type 2 in basal keratinocytes enhances papilloma formation in transgenic mice.
    Zhou HM; Bolon I; Nichols A; Wohlwend A; Vassalli JD
    Cancer Res; 2001 Feb; 61(3):970-6. PubMed ID: 11221892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of tumorigenicity in somatic cell hybrids. II. Human chromosomes implicated as suppressors of tumorigenicity in hybrids with Chinese hamster ovary cells.
    Klinger HP; Shows TB
    J Natl Cancer Inst; 1983 Sep; 71(3):559-69. PubMed ID: 6577230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant conversion of murine squamous papilloma cell lines by transfection with the fos oncogene.
    Greenhalgh DA; Yuspa SH
    Mol Carcinog; 1988; 1(2):134-43. PubMed ID: 2475137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional control of high molecular weight keratin gene expression in multistage mouse skin carcinogenesis.
    Roop DR; Krieg TM; Mehrel T; Cheng CK; Yuspa SH
    Cancer Res; 1988 Jun; 48(11):3245-52. PubMed ID: 2452688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of oncogenes and tumor suppressor genes in multistage carcinogenesis.
    Yuspa SH; Długosz AA; Cheng CK; Denning MF; Tennenbaum T; Glick AB; Weinberg WC
    J Invest Dermatol; 1994 Nov; 103(5 Suppl):90S-95S. PubMed ID: 7963691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ras gene activation and aberrant expression of keratin K13 in ultraviolet B radiation-induced epidermal neoplasias of mouse skin.
    Sutter C; Strickland PT; Mukhtar H; Agarwal R; Winter H; Schweizer J
    Mol Carcinog; 1993; 8(1):13-9. PubMed ID: 7688967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of somatic cell hybrids derived from normal human prostatic epithelial cells fused with HeLa cells.
    Peehl DM; Wong ST; McNeal JE; Stamey TA
    Prostate; 1990; 17(2):123-36. PubMed ID: 1697966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p21(WAF1/Cip1) functions as a suppressor of malignant skin tumor formation and a determinant of keratinocyte stem-cell potential.
    Topley GI; Okuyama R; Gonzales JG; Conti C; Dotto GP
    Proc Natl Acad Sci U S A; 1999 Aug; 96(16):9089-94. PubMed ID: 10430900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.